Transcutaneous Electrical Nerve Stimulator to Improve Blood Glucose Control in Patients With Type 2 Diabetes Mellitus

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT03102424

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Taiwan Resonant Waves Research Corporation (from the registry)
Registry
  • NCT NCT03102424
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03102424. Randomized; quadruple masking; primary purpose supportive care. Start 2017-04-10 (actual); primary completion 2020-07-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Transcutaneous Electrical Nerve Stimulator to Improve Blood Glucose Control in Patients With Type 2 Diabetes Mellitus
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
Transcutaneous Electrical Nerve Stimulator (DW1330)
Intervention (Device)
Sham DW1330 device
Lead sponsor
Taiwan Resonant Waves Research Corporation (class: industry)

Record details

Record id
cardio:ct-nct03102424
Content hash
a0d1b1e08599ddbea4aaf97d4880a3d3d14e5f08fda9ca62561891065a3b7e2e